Skip to main content
. 2006 Jan 25;2006(1):CD003746. doi: 10.1002/14651858.CD003746.pub2

Comparison 1. Anticoagulant vs Phenylbutazone.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Fatal PE 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
2 Non‐fatal PE 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3 Recurrent DVT/DVT extension (total) 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
4 Recurrent DVT/DVT extension (symptomatic) 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
5 Major hemorrhage 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
6 Fatal hemorrhage 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
7 All‐cause mortality 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
8 30 day venography ‐ distal veins ‐ progression or new lesions 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
9 Distal veins ‐ unchanged 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
10 Distal veins ‐ regression 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
11 Proximal veins ‐ progression or new lesions 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
12 Proximal veins ‐ unchanged 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
13 Proximal veins ‐ regression 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
14 V/Q at 10 days ‐ progression or new lesions 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
15 V/Q at 10 days ‐ unchanged 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
16 V/Q at 10 days ‐ regression 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
17 V/Q at 60 days ‐ progression or new lesions 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
18 V/Q at 60 days ‐ unchanged 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
19 V/Q at 60 days ‐ regression 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
20 Progression or new DVT at 3 months 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
21 Progression or new PE at 3 months 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
22 Progression or new VTE at 3 months ‐ DVT and PE 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected